JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
651
Vanguard Short-Term Corporate Bond ETF
VCSH
$44B
| $97.5M | 0.02% |
1,222,286
-2,026,861
| -62% | -$160M |
2013 Q2
23 quarters
|
|
652
Teradyne
TER
$70.2B
| $97.5M | 0.02% |
2,446,405
+1,033,287
| +73% | +$38.6M |
2013 Q2
23 quarters
|
|
|
EA
653
PUT
DELISTED
Electronic Arts
EA
| $97.1M | 0.02% |
955,600
-363,100
| -28% | -$34.4M |
2017 Q2
7 quarters
|
|
|
SHLX
654
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $96.7M | 0.02% |
4,727,167
-573,530
| -11% | -$11M |
2015 Q1
16 quarters
|
|
655
LCI Industries
LCII
$2.01B
| $96.5M | 0.02% |
1,255,963
-5,877
| -0.5% | -$465K |
2013 Q2
23 quarters
|
|
|
MDSO
656
DELISTED
Medidata Solutions, Inc.
MDSO
| $96.5M | 0.02% |
1,317,325
-45,296
| -3% | -$3.27M |
2015 Q4
13 quarters
|
|
657
Canadian Imperial Bank of Commerce
CM
$101B
| $96.3M | 0.02% |
2,435,350
+51,342
| +2% | +$2.13M |
2013 Q2
23 quarters
|
|
658
Carter's
CRI
$1.16B
| $96.3M | 0.02% |
955,219
-36,727
| -4% | -$3.28M |
2015 Q1
16 quarters
|
|
|
EQM
659
DELISTED
EQM Midstream Partners, LP
EQM
| $96.2M | 0.02% |
2,082,870
-276,195
| -12% | -$12.1M |
2013 Q2
23 quarters
|
|
660
RH
RH
$2.28B
| $96M | 0.02% |
932,117
-109,143
| -10% | -$14.9M |
2013 Q2
23 quarters
|
|
|
EA
661
CALL
DELISTED
Electronic Arts
EA
| $95.6M | 0.02% |
940,200
-4,809,400
| -84% | -$456M |
2017 Q2
7 quarters
|
|
662
NRG Energy
NRG
$20B
| $95.4M | 0.02% |
2,246,703
-542,932
| -19% | -$22.5M |
2013 Q2
23 quarters
|
|
663
PUT
Alphabet (Google) Class A
GOOGL
$4.2T
| $95.1M | 0.02% |
1,616,000
-1,910,000
| -54% | -$108M |
2016 Q1
12 quarters
|
|
664
ICICI Bank
IBN
$98.5B
| $94.9M | 0.02% |
8,282,064
+3,005,791
| +57% | +$31.2M |
2013 Q2
23 quarters
|
|
|
IDTI
665
DELISTED
Integrated Device Technology I
IDTI
| $94.8M | 0.02% |
1,934,415
+1,080,653
| +127% | +$52.3M |
2013 Q2
23 quarters
|
|
666
Bankunited
BKU
$3.09B
| $94.4M | 0.02% |
2,826,488
-287,730
| -9% | -$9.92M |
2013 Q2
23 quarters
|
|
667
Evolent Health
EVH
$391M
| $94.1M | 0.02% |
7,482,547
+366,226
| +5% | +$5.8M |
2015 Q2
15 quarters
|
|
668
CALL
Teva Pharmaceutical Industries Limited
TEVA
$46.1B
| $93.7M | 0.02% |
+5,977,500
| New | +$105M |
2019 Q1
0 quarters
|
|
|
CLGX
669
DELISTED
Corelogic, Inc.
CLGX
| $93.7M | 0.02% |
2,514,499
-355,623
| -12% | -$13.1M |
2013 Q2
23 quarters
|
|
670
PUT
Bristol-Myers Squibb
BMY
$125B
| $93.5M | 0.02% |
1,959,300
+1,129,600
| +136% | +$56.3M |
2014 Q2
19 quarters
|
|
671
JPMorgan International Bond Opportunities ETF
JPIB
$2.2B
| $93.4M | 0.02% |
1,902,058
-60,156
| -3% | -$2.92M |
2017 Q2
7 quarters
|
|
|
ABMD
672
DELISTED
Abiomed Inc
ABMD
| $93.3M | 0.02% |
326,830
-142,084
| -30% | -$47.2M |
2015 Q3
14 quarters
|
|
673
Acushnet Holdings
GOLF
$4.89B
| $93.2M | 0.02% |
4,029,731
-86,952
| -2% | -$2.03M |
2016 Q4
9 quarters
|
|
|
CISN
674
DELISTED
Cision Ltd. Ordinary Share
CISN
| $93.2M | 0.02% |
6,766,580
-275,918
| -4% | -$3.56M |
2017 Q2
7 quarters
|
|
675
Fortive
FTV
$17.4B
| $93.2M | 0.02% |
1,761,136
-220,920
| -11% | -$10.8M |
2016 Q3
10 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.